866-997-4948(US-Canada Toll Free)

Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the global Chemotherapy-Induced Nausea and Vomiting Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Chemotherapy-Induced Nausea and Vomiting Drugs market competition by top manufacturers/players, with Chemotherapy-Induced Nausea and Vomiting Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs for each application, including
Serotonin Receptor Antagonists
NK1 Receptor Antagonists

Table of Contents

Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Report 2017
1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting Drugs by Product Category
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Existing Drugs
1.2.4 Akynzeo (Netupitant-Palonosetron FDC)
1.2.5 Aloxi (Palonosetron)
1.2.6 Emend (Aprepitant)
1.2.7 Kytril Generic (Granisetron)
1.2.8 Zofran Generic (Ondansetron)
1.2.9 Pipeline Drugs
1.2.10 SUSTOL (Granisetron Injection extended release)
1.2.11 Rolapitant
1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application/End Users
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2012-2022)
1.4.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2012-2022)
1.4.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2012-2022)
1.4.5 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2012-2022)
1.4.7 India Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Chemotherapy-Induced Nausea and Vomiting Drugs (2012-2022)
1.5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2022)

2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Players/Suppliers
2.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs (Volume and Value) by Type
2.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs (Volume and Value) by Region
2.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs (Volume) by Application

3 United States Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price)
3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
3.1.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Trend (2012-2017)
3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Players
3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Type
3.4 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Application

4 China Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price)
4.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
4.1.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Trend (2012-2017)
4.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Players
4.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Type
4.4 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Application

5 Europe Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price)
5.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
5.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Trend (2012-2017)
5.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Players
5.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Type
5.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Application

6 Japan Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price)
6.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
6.1.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Trend (2012-2017)
6.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Players
6.3 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Type
6.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Application

7 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Application

8 India Chemotherapy-Induced Nausea and Vomiting Drugs (Volume, Value and Sales Price)
8.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Value (2012-2017)
8.1.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Trend (2012-2017)
8.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Players
8.3 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Type
8.4 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Market Share by Application

9 Global Chemotherapy-Induced Nausea and Vomiting Drugs Players/Suppliers Profiles and Sales Data
9.1 Merck & Co., Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 GlaxoSmithKline plc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Tesaro, Inc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Helsinn Group
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Heron Therapeutics, Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Dr. Reddy's Laboratories Ltd.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Acacia Pharma
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Sun Pharmaceutical Industry Ltd.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Otsuka Holdings Co., Ltd.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Chemotherapy-Induced Nausea and Vomiting Drugs Maufacturing Cost Analysis
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
10.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (2017-2022)
14.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price and Trend Forecast (2017-2022)
14.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Type (2017-2022)
14.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Existing Drugs Product Picture
Figure Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure Aloxi (Palonosetron) Product Picture
Figure Emend (Aprepitant) Product Picture
Figure Kytril Generic (Granisetron) Product Picture
Figure Zofran Generic (Ondansetron) Product Picture
Figure Pipeline Drugs Product Picture
Figure SUSTOL (Granisetron Injection extended release) Product Picture
Figure Rolapitant Product Picture
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2016
Figure Serotonin Receptor Antagonists Examples
Figure NK1 Receptor Antagonists Examples
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers
Figure 2017 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players
Table 2017 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2012-2017)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Type (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2012-2017)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2012-2017)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Region in 2016
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2012-2017)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate by Region in 2016
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2012-2017)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2016
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2012-2017)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application in 2016
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players in 2016
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type in 2016
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application in 2016
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players in 2016
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type in 2016
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application in 2016
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players in 2016
Table Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type in 2016
Table Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application in 2016
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Players in 2016
Table India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type in 2016
Table India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Application in 2016
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Tesaro, Inc. Basic Information List
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Helsinn Group Basic Information List
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Heron Therapeutics, Inc. Basic Information List
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Dr. Reddy's Laboratories Ltd. Basic Information List
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Acacia Pharma Basic Information List
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Sun Pharmaceutical Industry Ltd. Basic Information List
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Otsuka Holdings Co., Ltd. Basic Information List
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Global Market Share (2012-2017
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Players in 2016
Table Major Buyers of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Distributors/Traders List
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *